The AAP's new recommendations for pediatric COVID-19 vaccines clash with CDC guidance, prompting HHS Secretary Kennedy to issue a warning about potential liability for physicians. Experts respond.
Eli Lilly announces a dramatic price increase for its diabetes medication Mounjaro in the UK, raising the monthly cost from £122 to £330. This change affects private buyers but not NHS prescriptions. Learn more about the implications!
In a shocking twist, Senator Josh Hawley proposes repealing Medicaid cuts he supported just weeks prior. This move has sparked widespread mockery and highlights the complexities within the GOP as they navigate Trump's influence.
President Trump's controversial healthcare bill aims to cut $1.1 trillion from Medicaid over the next decade, risking coverage for millions and jeopardizing rural hospitals. With a razor-thin majority in the House, the bill's fate remains uncertain.
A new Senate bill could strip health insurance from 17 million Americans by unraveling key components of the Affordable Care Act, raising urgent concerns about Medicaid cuts and rising healthcare costs.
In a divisive ruling, the Supreme Court has upheld Tennessee's law banning gender-affirming care for minors, igniting fierce debates over youth rights and medical ethics. Advocates argue it violates equal protection, while supporters hail it as necessary for child safety.
The Trump administration's decision to revoke guidance requiring hospitals to provide emergency abortions raises serious concerns for women's health, especially in states with strict abortion bans. Advocates warn this could lead to dangerous consequences for pregnant women in medical emergencies.
Robert F. Kennedy Jr. canceled a critical $766 million contract with Moderna for a bird flu vaccine, raising concerns about public health and vaccine safety amidst a potential outbreak.
Pharma faces a daunting challenge as Trump takes bold steps to cut drug prices. With RFK Jr. praising the move, is bipartisanship on the horizon or will the industry fight back?
In a groundbreaking move, President Trump has issued an executive order aimed at ending the price discrimination faced by American consumers in the pharmaceutical market. This order seeks to ensure that Americans pay the same low prices for medications as those in other developed nations, addressing the long-standing issue of subsidizing global pharmaceutical profits.
